Digestive Diseases and Sciences

, Volume 40, Issue 3, pp 503–509 | Cite as

Ketotifen ameliorates capsaicin-augmented acetic acid-induced colitis

  • R. Eliakim
  • F. Karmeli
  • E. Okon
  • D. Rachmilewitz
Intestinal Disorders, Inflammatory Bowel Disease, Immunology, And Microbiology

Abstract

Capsaicin-sensitive afferent neurons are involved in maintaining the integrity of the gastro-intestinal mucosa. These neurons are closely apposed to mast cells and could, therefore, lead to their activation. In the present study, the role of capsaicin-sensitive neurons in the pathogenesis of experimental colitis and the possible involvement of mast cells and nitric oxide were evaluated. Rats were treated with capsaicin subcutaneously, 20, 30, and 50 mg/kg, on three consecutive days, a regimen shown to ablate primary afferent neurons. Colitis was induced two weeks later by flushing 2 ml 5% acetic acid into the proximal colon. Control rats received saline, acetic acid, or capsaicin alone. Another group of rats received ketotifen (100 µg/100 g body wt × 2/day) intragastrically 48 hr prior to damage induction and thereafter. Rats were sacrificed 24 hr after damage induction, the colon isolated, damage assessed, explants were organ-cultured for 24 hr for determination of nitric oxide generation, and mucosa extracted for determination of leukotriene B4 generation and nitric oxide synthase activity. Significant increases in colonic weight, nitric oxide synthase activity, and nitric oxide and leukotriene B4 generation accompanied the near tripling of acetic acid-induced damage in capsaicin-pretreated rats. Ketotifen pretreatment significantly decreased the macroscopic damage and the increase in colonic weight. The protection provided by ketotifen was accompanied by a significant decrease in leukotriene B4 generation and nitric oxide synthase activity (80%). The correlation between the extent of colonic damage, nitric oxide synthase activity, and nitric oxide generation in acetic acid-induced colitis in capsaicin-pretreated rats suggests possible involvement of nitric oxide in its pathogenesis. The protective effect of ketotifen in capsaicin-pretreated rats indicates that mast cell activation is not prevented by ablation of afferent neurons.

Key Words

capsaicin acetic acid colitis NO ketotifen 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Eliakim R, Rachmilewitz D: Potential mediators in inflammatory bowel disease. Gastroenterol Int 5:48–56, 1992Google Scholar
  2. 2.
    Mannaioni PF, Masini E, Pistelli A, Salvemini D, Vane JR: Mast cells as a source of superoxide anions and nitric oxide-like factor: Relevance to histamine release. Int J Tissue Reac 13:271–278, 1991Google Scholar
  3. 3.
    Kanwar S, Wallace JL, Befus D, Kubes P: Nitric oxide modulates mucosal barrier function: A potential role of mast cells. Gastroenterology 105:A249, 1993Google Scholar
  4. 4.
    Oates PJ, Hakkinen JP: Studies on the mechanism of ethanol induced gastric damage in rats. Gastroenterology 94:10–21, 1988PubMedGoogle Scholar
  5. 5.
    Rioux KP, Wallace JL: Activation of mucosal mast cells augments gastric mucosal injury. Gastroenterology 105:A401, 1993Google Scholar
  6. 6.
    Stead RH, Tomioka M, Riddell RH, Bienenstock J: Substance P and/or calcitonin gene related peptide are present in subepithelial enteric nerves apposed to intestinal mucosal mast cells.In: Inflammatory Bowel Disease: Current Status and Future Approach. RP MacDermott (ed). Amsterdam, Elsevier Scientific Publications, 1988, pp 43–48Google Scholar
  7. 7.
    Whittle BJR, Lopez-Belmonte J: Gastric mucosal damage and protection: Involvement of novel endothelium-derived mediators. In: The Stomach, Physiology, Pathophysiology and Treatment. W Domschke, SJ Konturek (eds). Berlin, Springer-Verlag, 1993, pp 68–82Google Scholar
  8. 8.
    Lambrecht N, Butchert H, Responde KM, Muller K-M, Peskar BM: Role of calcitonin gene-related peptide and nitric oxide in the gastroprotective effect of capsaicin. Gastroenterology 104:1371–1380, 1993PubMedGoogle Scholar
  9. 9.
    Wang L, Stanisz AM, Perdue MH: Activation of mast cells by substance P in the regulation of ion secretion in mouse small intestine. Gastroenterology 104:A156, 1993Google Scholar
  10. 10.
    Wallace JL, McKnight GW, Befus D: Capsaicin induced hyperemia in the stomach: Possible contribution of mast cells. Am J Physiol 263:G209-G214, 1992PubMedGoogle Scholar
  11. 11.
    Crowe SE, Perdue MH: Gastrointestinal food hypersensitivity: Basic mechanisms of pathophysiology. Gastroenterology 103:1075–1095, 1992PubMedGoogle Scholar
  12. 12.
    Eliakim R, Karmeli F, Okon E, Rachmilewitz D: Ketotifen effectively prevents mucosal damage in experimental colitis. Gut 33:1498–1503, 1992PubMedGoogle Scholar
  13. 13.
    Pothoulakis C, Karmeli F, Kelly CP, Eliakim R, Joshi MA, O'Keane CJ, Castaglivolo I, LaMont JT, Rachmilewitz D: Ketotifen inhibits clostridium difficile toxin A-induced enteritis in rat ileum. Gastroenterology 105:701–707, 1993PubMedGoogle Scholar
  14. 14.
    Szolcanyi J, Bartho L: Impaired defense mechanism to peptic ulcer in the capsaicin desensitized rat. In: Advanced Physiological Sciences, Vol 15, Gastrointestinal Defense Mechanisms. GY Mozsic, O Hanninen, T Javor (eds). Oxford, Pergamon Press, 1981, pp 39–51Google Scholar
  15. 15.
    Martling CR: Sensory nerves containing tachykinins and cGRP in the lower airways. Acta Physiol Scand 563(suppl):1–57, 1987Google Scholar
  16. 16.
    Rachmilewitz D, Stamler JS, Karmeli F, Mullins ME, Singel DJ, Loscalzo J, Xavier RJ, Podolsky DK: Peroxynitrite-induced rat colitis—a new model of colonic inflammation. Gastroenterology 105:1681–1688, 1993PubMedGoogle Scholar
  17. 17.
    Bush PA, Gonzalez NE, Griscavage JM, Ignarro LJ: Nitric oxide synthase from cerebellum catalyzes the formation of equimolar quantities of nitric oxide and citrulline froml-arginine. Biochem Biophys Res Commun 185:960–966, 1992PubMedGoogle Scholar
  18. 18.
    Sharkey KA, Williams RG, Dockray GJ: Sensory substance P innervation of the stomach and pancreas. Demonstration of capsaicin-sensitive sensory neurons in the rat by combined immunohistochemistry and retrograde tracing. Gastroenterology 87:914–921, 1984PubMedGoogle Scholar
  19. 19.
    Leung FN: Role of capsaicin-sensitive afferent nerves in mucosal injury and injury-induced hyperemia in rat colon. Am J Physiol 262:G332–337, 1992PubMedGoogle Scholar
  20. 20.
    Domek MJ, Blackman E, Vidrich A, Kao J, Baker M, Leung FW: Capsaicin pretreatment increases severity of dextran sulfate sodium (DSS)-induced colonic damage in rats. Gastroenterology 105:A615, 1993Google Scholar
  21. 21.
    Reinshagen M, Patel A, Sottili M, Procaccino F, French S, Eysslein VE: Effect of sensory neurons in chronic colitis. Gastroenterology 105:A173, 1993Google Scholar
  22. 22.
    Barret KE: Involvement of histamine in a rat model of inflammatory bowel disease. Gastroenterology 98:A653, 1990Google Scholar
  23. 23.
    Rachmilewitz D, Stamler JS, Bachwich D, Karmeli F, Ackerman Z, Loscalzo J, Podolsky DK: Enhanced colonic NO generation and stimulated NO synthase activity in experimental colitis and in active inflammatory bowel disease. Gastroenterology 105:A236, 1993Google Scholar
  24. 24.
    Boughton-Smith NK, Evans SM, Cole AT, Hawkey CJ, Whittle BJR, Moncada S: Induction of nitric oxide synthase in inflamed colon from ulcerative colitis patients. Gastroenterology 105:A236, 1993Google Scholar
  25. 25.
    Mourelle M, Videla S, Vilaseca J, Guarner F, Malagelada JR: Induction of nitric oxide synthase in the course of toxic megacolon in a rat model of colitis. Gastroenterology 105:A237, 1993Google Scholar
  26. 26.
    Miller HJS, Sadowska-Krowicka A, Chotinaruemol S, Kakkis JL, Clark DA: Amelioration of chronic ileitis by nitric oxide synthase inhibition. J Pharmacol Exp Ther 264:11–16, 1993PubMedGoogle Scholar
  27. 27.
    Stenson WF, Lauristen K, Laursen LS, Rask-Madsen J, Jacobsen O, Naesdal J, Cort D, Goebell H, Peskar B, Hanaver S, Swanson L, Dube L, Rubin P: A clinical trial of Zileuton, a specific inhibitor of 5-lipoxygenase in ulcerative colitis. Gastroenterology 100:A253, 1991.Google Scholar
  28. 28.
    Sharon P, Stenson WF: Enhanced synthesis of leukotriene B4 by colonic mucosa in inflammatory bowel disease. Gastroenterology 86:453–460, 1984PubMedGoogle Scholar
  29. 29.
    Wallace JL, MacNaughton WK, Morris GP, Beck PL: Inhibition of leukotriene synthesis markedly accelerated healing in a rat model of inflammatory bowel disease. Gastroenterology 96:29–36, 1989PubMedGoogle Scholar
  30. 30.
    Fretland DJ, Levin S, Tsai BS, Djuric SW, Widomski DL, Zemaitis JM, Shone RL, Bauer RF: The effect of leukotriene B4 receptor antagonist, SC-41930, on acetic acid induced colonic inflammation. Agents Actions 27:395–397, 1989PubMedGoogle Scholar

Copyright information

© Plenum Publishing Corporation 1995

Authors and Affiliations

  • R. Eliakim
    • 1
    • 2
  • F. Karmeli
    • 1
    • 2
  • E. Okon
    • 1
    • 2
  • D. Rachmilewitz
    • 1
    • 2
  1. 1.From the Department of MedicineHadassah University Hospital, Hebrew University Hadassah Medical SchoolJerusalemIsrael
  2. 2.From the Department of PathologyHadassah University Hospital, Hebrew University Hadassah Medical SchoolJerusalemIsrael

Personalised recommendations